Cited by 49SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyCOVID-19 epidemiological studies

Coronavirus Disease 2019 Vaccine Impact on Rates of Severe Acute Respiratory Syndrome Coronavirus 2 Cases and Postvaccination Strain Sequences Among Health Care Workers at an Urban Academic Medical Center: A Prospective Cohort Study

Open access
Bouton, Tara C, Lodi, Sara, Turcinovic, Jacquelyn, Schaeffer, Beau, Weber, Sarah E, Quinn, Emily, Korn, Cathy, Steiner, Jacqueline +10 more·2021·Open Forum Infectious Diseases

Published version of a preprint

Abstract

Background: Coronavirus disease 2019 (COVID-19) vaccine trials and post-implementation data suggest that vaccination decreases infections. We examine vaccination’s impact on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) case rates and viral diversity among health care workers (HCWs) during a high community prevalence period. Methods: In this prospective cohort study, HCW received 2 doses of BNT162b2 or mRNA-1273. We included confirmed cases among HCWs from 9 December 2020 to 23 February 2021. Weekly SARS-CoV-2 rates per 100,000 person-days and by time from first injection (1–14 and ≥15 days) were compared with surrounding community rates. Viral genomes were sequenced. Results: SARS-CoV-2 cases occurred in 1.4% (96/7109) of HCWs given at least a first dose and 0.3% (17/5913) of HCWs given both vaccine doses. Adjusted rate ratios (95% confidence intervals) were 0.73 (.53–1.00) 1–14 days and 0.18 (.10–.32) ≥15 days from first dose. HCW ≥15 days from initial dose compared to 1-14 days were more often older (46 vs 38 years, P = .007), Latinx (10% vs 8%, P = .03), and asymptomatic (48% vs 11%, P = .0002). SARS-CoV-2 rates among HCWs fell below the surrounding community, an 18% vs 11% weekly decrease, respectively (P = .14). Comparison of 50 genomes from post–first dose cases did not indicate selection pressure toward known spike antibody escape mutations. Conclusions: Our results indicate an early positive impact of vaccines on SARS-CoV-2 case rates. Post-vaccination isolates did not show unusual genetic diversity or selection for mutations of concern.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ofid/ofab465

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 25 · Cited by 49

Research works printed but not linked: 18

  1. Wang Z, Schmidt F, Weisblum Y, et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature 2021; 592:616-22.
  2. Bullard J, Dust K, Funk D, et al. Predicting infectious severe acute respira- tory syndrome coronavirus 2 from diagnostic samples. Clin Infect Dis 2020; 71:2663-6.
  3. Basile K, McPhie K, Carter I, et al. Cell-based culture of SARS-CoV-2 informs infectivity and safe de-isolation assessments during COVID-19 [manuscript pub- lished online ahead of print 24 October 2020]. Clin Infect Dis 2020. doi:10.1093/ cid/ciaa1579. · DOI
  4. Kim MC, Cui C, Shin KR, et al. Duration of culturable SARS-CoV-2 in hospital- ized patients with Covid-19. N Engl J Med 2021; 384:671-3.
  5. Wilm A, Aw PP, Bertrand D, et al. LoFreq: a sequence-quality aware, ultra- sensitive variant caller for uncovering cell-population heterogeneity from high- throughput sequencing datasets. Nucleic Acids Res 2012; 40:11189-201.
  6. National Center for Biotechnology Information. Severe acute respiratory syn- drome coronavirus 2 isolate Wuhan-Hu-1, complete genome. 2020. http://www. ncbi.nlm.nih.gov/nuccore/NC_045512.2. Accessed 28 October 2020.
  7. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods 2012; 9:357-9.
  8. Nguyen LT, Schmidt HA, von Haeseler A, Minh BQ. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol Biol Evol 2015; 32:268-74.
  9. Yu G, Lam TT, Zhu H, Guan Y. Two methods for mapping and visualizing associ- ated data on phylogeny using Ggtree. Mol Biol Evol 2018; 35:3041-3.
  10. Paradis E, Schliep K. ape 5.0: an environment for modern phylogenetics and evo- lutionary analyses in R. Bioinformatics 2019; 35:526-8.
  11. Amit S, Regev-Yochay G, Afek A, et al. Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients. Lancet 2021; 397:875-7.
  12. Keehner J, Horton LE, Pfeffer MA, et al. SARS-CoV-2 infection after vaccination in health care workers in California. N Engl J Med 2021; 384:1774-5.
  13. Daniel W, Nivet M, Warner J, Podolsky DK. Early evidence of the effect of SARS- CoV-2 vaccine at one medical center. N Engl J Med 2021; 384:1962-3.
  14. Thompson MG, Burgess JL, Naleway AL, et al. Interim estimates of vac- cine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first re- sponders, and other essential and frontline workers-eight U.S. locations, December 2020-March 2021. MMWR Morb Mortal Wkly Rep 2021; 70: 495-500.
  15. Burger AE, Reither EN, Mamelund SE, Lim S. Black-white disparities in 2009 H1N1 vaccination among adults in the United States: a cautionary tale for the COVID-19 pandemic. Vaccine 2021; 39:943-51.
  16. Moore S, Hill EM, Tildesley MJ, et al. Vaccination and non-pharmaceutical inter- ventions for COVID-19: a mathematical modelling study. Lancet Infect Dis 2021; 21:793-802.
  17. Saad-Roy CM, Morris SE, Metcalf CJE, et al. Epidemiological and evolu- tionary considerations of SARS-CoV-2 vaccine dosing regimes. Science 2021; 372:363-70.
  18. Krammer F, Srivastava K, Alshammary H, et al. Antibody responses in seropos- itive persons after a single dose of SARS-CoV-2 mRNA vaccine. N Engl J Med 2021; 384:1372-4.

Authors
Bouton, T. C., Lodi, S., Turcinovic, J., Schaeffer, B., Weber, S. E., Quinn, E., Korn, C., Steiner, J., Schechter-Perkins, E. M., Duffy, E., Ragan, E. J., Taylor, B. P., Miller, N., Davidoff, R., Hanage, W. P., Connor, J., Pierre, C., & Jacobson, K. R.
Affiliations
  • Boston University (US)
  • Harvard University (US)
  • Boston Medical Center (US)
  • Department of Emergency Medicine, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA
Corresponding author
Bouton, Tara C
Venue
Open Forum Infectious Diseases
Published
2021-09-17
Volume
8
Issue
10
Pages
ofab465-ofab465
ISSN
2328-8957 (ISSN-L)
OpenAlex
W3206421067
Cited by
49
References
25
Citations by year
2026: 1 · 2024: 1 · 2023: 5 · 2022: 22 · 2021: 19 · 2020: 1
FWCI
3.72
Type
journal article
Language
en
Open access
Locations
  • Open Forum Infectious Diseases (publishedVersion, cc-by)
  • medRxiv (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion)
Funders
  • National Institutes of Health (T32-DA013911;, 1UL1TR001430)
  • Burroughs Wellcome Fund
  • American Society for Tropical Medicine and Hygiene Postdoctoral Fellowship in Tropical Infectious Diseases
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Social Sciences › Health › Vaccine Coverage and Hesitancy
  • Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
Keywords
COVID-19 vaccines, SARS-CoV-2, healthcare workers, BNT162b2, mRNA-1273, vaccine effectiveness, breakthrough infection, viral genome sequencing, spike protein mutations, antibody escape mutations, viral genetic diversity, asymptomatic infection, academic medical centers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review